capiton AG

What they fund

Stage: Growth-stage, profitable mid-market companies [1]., Sector: High-Tech Industrials, Healthcare & Life Sciences, Consumer Goods, Food, and Software [1]., Geography: DACH region (Germany, Austria, Switzerland) [1]., Company Profile: Owner-managed businesses with annual revenues between €50 and €300 million [1]., Deal Shape: Majority stakes, often with a "Buy-and-Build" strategy to consolidate fragmented markets.

Investment thesis

Capiton AG is a mid-market private equity firm that invests in profitable, owner-managed companies in the DACH region with revenues between €50 and €300 million, aiming to reposition them for future growth through capital, operational know-how, and long-term partnership [1].

• Growth Driver — Investing in companies that are repositioning themselves for the future through capital, know-how, and commitment [2].
• Value Creation — Combining innovative ideas, market access, change expertise, and fresh capital to pave the way for the future [1].
• Operational Focus — Leveraging a deep understanding of mid-market challenges and long-term partnership to drive sustainable value [2].
• Strategic Approach — Utilizing a "Buy-and-Build" strategy, as seen in the Dec Group investment, to expand product portfolios and geographic reach.
• Market Position — Counting among the most successful mid-cap PE investors in the DACH region, with a focus on High-Tech Industrials, Healthcare, and Life Sciences [1].

Credibility: The thesis is derived from Capiton's official website, which details its investment strategy, portfolio focus, and value creation approach [1].

Value add

Capiton provides capital, market access, change expertise, and operational know-how to help portfolio companies reposition for future growth [1].

Fit verdict: Ideal for owner-managed mid-market companies in the DACH region seeking a long-term partner to drive operational transformation and growth.

Founder diligence script:

• What specific change expertise does Capiton bring to my industry?
• How does Capiton's "Buy-and-Build" strategy align with my growth plans?
• What is Capiton's track record in exiting portfolio companies, and what are the typical timelines?
• How does Capiton's ESG strategy impact my company's operations and valuation?

Portfolio focus

Healthcare & Life Sciences: Wundex, a leading healthcare service provider in Germany, grew from a regional player to a market leader with Capiton's support [1]., High-Tech Industrials: AEMtec Group, sold to Micross in 2026, and Anovis (a CymbiQ Group company), sold to x-tention Group in 2026 [1]., Consumer Goods: Tierliebhaber, a leading brand for pet supplements in Germany, acquired by AlphaPet Ventures in 2026 [1]., Food: Cpro Food, a premium dog and cat food brand in Belgium, acquired by AlphaPet Ventures in 2026 [1].

Notable investments & exits

AEMtec Group: Sold to Micross in July 2026 [1]., Anovis (CymbiQ Group): Sold to x-tention Group in March 2026 [1]., Prefere Resins: Sold to One Rock Capital Partners in July 2022, after being acquired from Capiton and Intermediate Capital Group in 2018 [3]., Trenkwalder Group: Capiton acquired a 25.4% stake in 2003 and sold it back in 2007 for €50 million [2].

Strategic implications

Capiton's edge lies in its deep understanding of the DACH mid-market and its operational value creation capabilities. Its focus on profitable, owner-managed companies allows it to negotiate favorable terms and drive significant growth. The main risk is over-reliance on the DACH region, which may limit diversification. A signal that would change the read is if Capiton expands its geographic focus or investment stage, which could indicate a shift in strategy or market conditions.

Where they could go further

Capiton could explore co-investment opportunities with international PE firms to access new markets and sectors. The firm could enhance its ESG strategy by setting more specific, measurable targets and reporting on progress. Capiton could develop a more robust platform for portfolio companies to share best practices and collaborate. The firm could consider investing in earlier-stage companies to build a pipeline for future growth.